Ipca Laboratories Limited

₹1,939As of Sun 8 Nov 2026, 12:00 UTC
NSE:IPCALABHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 20.44%
Div yield 0.31%
ROE 15.59%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.04
PE TTM 35.07
TSR TTM 53.04%
Mkt cap ₹491.9B
ROIC 15.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,262
16.67%
(22.03%)
Hold 8|2|2|11|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
30.61
30.32
33.52
36.89
31.03%
20.99%
26.14%
33.09%
Revenue₹B
53.35
52.24
52.82
53.29
4.19%
(0.39%)
(3.25%)
0.28%
Peers (US$5.236B)
Cap (US$)
PE
5.968B
33.91x
5.568B
42.33x
5.235B
16.68x
Capital
TTM
5Y
10Y
Leveragex
1.377
0.092
0.073
EBIT/Intx
0.754
0.955
0.713
Own earn%
(26.17)
(285.06)
(226.31)
Sh yield%
24.81
36.05
40.35
Owners
Insiders/Inst%
5.67
63.52
Short interest%
0.59
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–21
$1 testx
—
Incr. ROIC%
9